Tissue Therapies Limited Stock Australian S.E.
Equities
AU000000TIS8
Construction Materials
End-of-day quote
Other stock markets
|
||
- AUD | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.23M 4.72M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -1.31M | EV / Sales 2022 | - |
Net cash position 2022 | 3.69M 2.41M | Net cash position 2023 | 3.13M 2.04M | EV / Sales 2023 | - |
P/E ratio 2022 |
-12.1
x | P/E ratio 2023 |
-2.99
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.27% |
Managers | Title | Age | Since |
---|---|---|---|
Dominic Allen
CEO | Chief Executive Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Taso Arima
BRD | Director/Board Member | 40 | 21-10-31 |
David Brookes
CHM | Chairman | 63 | 19-04-09 |
Dominic Allen
CEO | Chief Executive Officer | - | 21-10-31 |
1st Jan change | Capi. | |
---|---|---|
-30.43% | 268M | |
-5.71% | 77.44M | |
-37.91% | 75.65M |